- West Pharmaceutical (NYSE:WST): Q3 Non-GAAP EPS of $1.15 beats by $0.16; GAAP EPS of $1.09 beats by $0.11.
- Revenue of $548M (+20.1% Y/Y) beats by $37.85M.
- Press Release
- https://seekingalpha.com/news/3624655-west-pharmaceutical-eps-beats-0_16-beats-on-revenue
Thursday, October 22, 2020
West Pharmaceutical EPS beats by $0.16, beats on revenue
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.